PAX3 is a biomarker and prognostic factor in melanoma: Database mining
Open Access
- 18 March 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (6) , 4985-4993
Abstract
Paired box 3 (PAX3) is a transcription factor and critical regulator of pigment cell development during embryonic development. However, while there have been several studies on PAX3, its expression patterns and precise role remain to be clarified. The present study is an in‑depth computational study of tumor‑associated gene information, with specific emphasis on the expression of PAX3 in melanoma, using Oncomine along with an investigation of corresponding expression profiles in an array of cancer cell lines through Cancer Cell Line Encyclopedia analysis. Based on Kaplan‑Meier analysis, the prognostic value of high PAX3 expression in tissues from patients with melanoma compared with normal tissues was assessed. PAX3 was more highly expressed in male patients with melanoma compared with female patients with melanoma. Using Oncomine and Coexpedia analysis, it was demonstrated that PAX3 expression was clearly associated with SRY‑box 10 expression. The survival analysis results revealed that high PAX3 mRNA expression was associated with worse survival rates in patients with melanoma. These results suggested that PAX3 may be a biomarker and essential prognostic factor for melanoma, and provided an important theoretical basis for the development of melanoma treatments.Keywords
This publication has 60 references indexed in Scilit:
- The gene expression signatures of melanoma progressionProceedings of the National Academy of Sciences, 2005
- Pax3 functions at a nodal point in melanocyte stem cell differentiationNature, 2005
- Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma PatientsJournal of Clinical Oncology, 2004
- Practical guidelines for the management of biochemotherapy-related toxicity in melanoma.2001
- PAX3 is expressed in human melanomas and contributes to tumor cell survival.2001
- Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndromeHuman Molecular Genetics, 2000
- Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3Human Genetics, 2000
- Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines.1999
- Pax3 and Regulation of the Melanocyte-specific Tyrosinase-related Protein-1 PromoterJournal of Biological Chemistry, 1999
- PAX3 gene structure, alternative splicing and evolutionGene, 1999